BCY LifeSciences Clarification

    TORONTO, April 13 /CNW/ - BCY LifeSciences Inc., (BCY) (TSX-VEN: BCY)
trading was halted at noon today, as market surveillance had difficulty in
contacting the company to clarify information.
    The Company has held a discussion with surveillance and answered the
questions needing clarification. Surveillance noted that the Company in its
release yesterday had listed an incorrect phone number. The number on this
release is the corrected number. The email address listed has not changed. The
Company apologizes to investors who may have been attempting to call the

    This news release contains projections and other forward-looking
statements regarding future events. Such statements are predictions, which may
involve known and unknown risks, uncertainties and other factors, which could
cause the actual events or results and company plans and objectives to differ
materially from those expressed. For information concerning factors affecting
the company's business, the reader is referred to the documents that the
company files from time to time with applicable Canadian securities and
regulatory authorities.

    The TSX Venture Exchange has not reviewed and does not accept
    responsibility for the adequacy or accuracy of this press release.

    %SEDAR: 00011471E

For further information:

For further information: Mr. Lorne Meikle, President & CEO, BCY
LifeSciences, Tel: (416) 440-1330, Email: lmeikle@bcylifesciences.com

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890